One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Addressing inequities in colorectal cancer
doi : 10.1016/S2468-1253(20)30309-5
Volume 5, Issue 11, November 2020, Page 955
Antibiotics: a trigger for inflammatory bowel disease?
HarrySokolabc
Intestinal motility: a therapeutic target for NAFLD?
Jörn MSchattenberga
SARS-CoV-2 infection in liver transplant recipients: collaboration in the time of COVID-19
Julie KHeimbachaTimucinTanera
COVID-19 as a barrier to attending for gastrointestinal endoscopy: weighing up the risks
Colin JReesaMatt DRutterbLindaSharpaBuHayeecJames EEastdPradeepBhandarieIanPenmanf
Incorporating standardised reporting guidelines in clinical trials of artificial intelligence in gastrointestinal endoscopy
MohammadBilalaJeremy R GlissenBrownaTyler MBerzina
COVID-19 vaccinations in patients with inflammatory bowel disease
AditiKumarabMohammed NabilQuraishicdJonathan PSegaleTimRainefMatthew JBrookesab
Effect of the COVID-19 pandemic on viral hepatitis services in sub-Saharan Africa
MaudLemoineaJin UnKimaGibrilNdowabSulaymanBahbKarenForrestbJohnRwegashacMarielleBouyoudDelphineNaponeSostheneSomdafAppolinaireSawadogogRogerSombiefYusukeShimakawah
The Digital International Liver Congress 2020
SheilaPinionHughThomasRobBrierley
A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation study
ProfStephen AHarrisonMDab*ProfVladRatziuMDc*ProfJérômeBoursierMDdeProfSvenFrancqueMDfgProfPierreBedossaMDhiZouherMajdPhDjGenevièveCordonnierPhDjFouad BenSudrikMScjRaphaelDarteilPhDjkRomanLiebePhDjlJérémyMagnanensiPhDjYacineHajjiMScjJohnBrozekMScjAliceRoudotPharmDjProfBartStaelsPhDmDean WHumPhDjSophie JeanninMegnienMDajSuneilHosmanePhDj…ProfArun JSanyalMDoâ€
Antibiotic use and the development of inflammatory bowel disease: a national case-control study in Sweden
Long HNguyenMDabAnne KÖrtqvistMDcfYinCaoScDbghTracey GSimonMDabBjornRoelstraetePhDdMingyangSongScDabijAmit DJoshiPhDabKyleStallerMDabProfAndrew TChanMDabklHamedKhaliliMDabOlaOlénMDcemProfJonas FLudvigssonMDdnop
Lubiprostone in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled, phase 2a trial
TakaomiKessokuMDadKentoImajoMDaTakashiKobayashiMDaAnnaOzakiMDaMichihiroIwakiMDaYasushiHondaMDadTakayukiKatoMDagYujiOgawaMDaWataruTomenoMDagShingoKatoMDaTakumaHigurashiMDaMasatoYonedaMDaHiroyukiKirikoshiMDeKazumiKubotaPhDbProfMasatakaTaguriPhDcProfTakeharuYamanakaPhDbHarukiUsudaPhDhProfKoichiroWadaPhDh…ProfAtsushiNakajimaMDa
Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study
Gwilym JWebbPhDa†ThomasMarjotMRCPa†Jonathan ACookPhDbCosticaAlomanMDcMatthew JArmstrongPhDdErica JBrennerMDeMaria-AndreeaCatanaMDgTamsinCargillMRCPaRenumathyDhanasekaranMDiIgnacioGarcÃa-JuárezMDjHannesHagströmMDkJames MKennedyMRCPaAileenMarshallFRCPlStevenMassonFRCPmnCarolyn JMercerMRCPaPonni VPerumalswamiMDoIsaacRuizMDpSarangThakerMDq…Andrew MMoonMDfâ€
Nutritional approaches for gastroparesis
Berkeley NLimketkaiMDaWendiLeBrettMDaLisaLinMDaNeha DShahRDb
